OR OTHER RELATIONSHIP(S) DISCLOSURE:

Similar documents
Disclosure. Learning Objectives 6/4/2014. Medication Adherence: Challenges and Opportunities

MEDICATION ADHERENCE: WE DIDN T ASK & THEY DIDN T TELL

To Take or Not To Take?

The University of Mississippi School of Pharmacy

Cost-Effective Process to Improve Drug Adherence for Medicare 5-Star

Measurement Name Beta-Blocker Therapy Prior Myocardial Infarction (MI)

Is it worth offering cardiovascular disease prevention to the elderly? Prof. Dr. Helmut Gohlke Herz-Zentrum Bad Krozingen, Germany

Quality Payment Program: Cardiology Specialty Measure Set

Getting Hypertension Under Control

Medications. Your prescriptions can be filled by your home pharmacy or by the Michigan Medicine Taubman Center outpatient pharmacy.

5/2/2016. Outpatient Stroke Management Sheila Smith MD May 5, 2016

MEDICINES ADHERENCE The Role of the Pharmacist

Implementation of JNC- 8 Hypertension Recommendations: Combining evidence and value-based practice strategies for accountable care

Should All Patients Be Treated with Ace-inh /ARB after STEMI with Preserved LV Function?

Is it ever too late for cardiovascular prevention and rehabilitation? Prof. Dr. Helmut Gohlke Herz-Zentrum Bad Krozingen, Germany

6/1/18 LEARNING OBJECTIVES PATIENT POPULATION PRESENTATIONS

2015 Healthy Heart. Program Evaluation. Our mission is to improve the health and quality of life of our members

10-Year Mortality of Older Acute Myocardial Infarction Patients Treated in U.S. Community Practice

Quality Payment Program: Cardiology Specialty Measure Set

Addressing the Problem of Health Literacy: Practical Approaches in Practice

Adherence to medication in cardiovascular disease

Calculating Risk for Primary Prevention of Cardiovascular Disease (CVD)

DECLARATION OF CONFLICT OF INTEREST

Fasting or non fasting?

Improving Adherence to Chronic Medications: The Physicians Role and How 340b Can Help

Presenter Disclosure Information

ACE inhibitors: still the gold standard?

Practice-Level Executive Summary Report

Improve the Adherence, Save the Life

Role of Clopidogrel in Acute Coronary Syndromes. Hossam Kandil,, MD. Professor of Cardiology Cairo University

Κώστας Τσιούφης Iπποκράτειο Γ.Ν.Α

Beta-blockers in Patients with Mid-range Left Ventricular Ejection Fraction after AMI Improved Clinical Outcomes

Toledo Hospital Clinical Quality Indicators. Effective - Heart Attack

Cardiovascular Health Practice Guideline Outpatient Management of Coronary Artery Disease 2003

Cardiovascular Guideline-Driven Pharmacotherapies: Optimizing Management

Rethink. Adherence. David D. Pope, PharmD, CDE Editor-in-Chief, CreativePharmacist.com Brands

Section 5 Treatment and health service provision

Performance and Quality Measures 1. NQF Measure Number. Coronary Artery Disease Measure Set

How pharmacy and retail health can support health and wellness. Nancy Gagliano Chief Medical Officer, MC September, 2014

Best Practices in Cardiac Care: Getting with the Guidelines

3/6/2017. Grassroots Strategies for Improving Adherence. Learning Objectives

e-module Centers for Medicaid and Medicare (CMS) Core Measures

Program Metrics. New Unique ID. Old Unique ID. Metric Set Metric Name Description. Old Metric Name

Diabetes and the Heart

Long-Term Management Of the ACS Patient: State-of-the-Art. Kim Newlin, CNS, NP-C, FPCNA Sutter Roseville Medical Center Roseville, CA

Statins ARE Enough For The Prevention of CVD! Professor Kausik Ray Imperial College London, UK

Advances in Cardiovascular Diagnosis and Therapy. No disclosure or conflicts. Outline

Patient Navigator Program: Focus MI Diplomat Hospital Metrics

Performance Outcomes: Measure & Metric Details

The table below includes the quality measures an ACO is required to submit to CMS as a participant in an MSSP Track 3 ACO

Disclosures. Speaker s bureau: Research grant: Advisory Board: Servier International, Bayer, Merck Serono, Novartis, Boehringer Ingelheim, Lupin

Potential synergy between lipid-lowering and blood-pressure-lowering, and Single pill benefit in patient s adherence

HEALTHCARE REFORM. September 2012

Management of Stable Ischemic Heart Disease. Vinay Madan MD February 10, 2018

Section 5 Treatment and health service provision

Consensus Core Set: ACO and PCMH / Primary Care Measures Version 1.0

Mary Catherine Beach, MD, MPH Johns Hopkins University Baltimore, MD

RCCO Quality Indicators Crosswalk

Preventive Cardiology Scientific evidence

Interdependence of Evidence-based Practice & Shared Decision Making Implications for Quality

Disclosures. Theodore A. Bass MD, FSCAI. The following relationships exist related to this presentation. None

40% minimum reduction from

LIPITOR AND YOU HELPFUL INFORMATION FOR UNDERSTANDING CHOLESTEROL AND RISKS

Literacy and Adherence

Treatment of Cardiovascular Risk Factors. Kevin M Hayes D.O. F.A.C.C. First Coast Heart and Vascular Center

Hypertension and the Challenge of Adherence. Geneva Clark Briggs, Pharm.D., BCPS

The Changing Epidemiology of Acute Coronary Syndromes: Implications for practice: Dr. Sonia Anand, McMaster University

Your Partnership in Health Report: Chronic Conditions ABC Company and Kaiser Permanente

Economics of Reducing Out-of-Pocket Costs for Cardiovascular Preventive Services for Patients with High Blood Pressure and High Cholesterol

Pharmacy Clinical Support Technician. Cardiac Sciences Program

Table 1. Proposed Measures for Use in Establishing Quality Performance Standards that ACOs Must Meet for Shared Savings

Consensus Core Set: Cardiovascular Measures Version 1.0

Population models of health impact of combination polypharmacy

Medication Adherence: How Much is Enough?

The Problem of CV Drug Adherence Worldwide

Get With The Guidelines: Lessons for National Healthcare Improvement Programs

Blue Shield Participation

Behavioral Health Treatment in a Primary Care Setting

The Clinical Debates

Exercise after CABG: The Good The Bad and the Ugly

Preventive Cardiology

Coronary Heart Disease in Women Go Red for Women

Disclosures. Preventing Heart Failure Re-admissions in Deaths Due to Cardiovascular Disease (United States: ) Heart Failure

ADHERTENCE AND COMPLIANCE TO TREATMENTS

Patient Adherence Claire Neely, MD

Better CABGs vs Better PCI Devices

ENSURING EXCELLENCE IN PRESCRIBING FOR OLDER ADULTS

Outcomes and Perspectives of Single-Pill Combination Therapy for the modern management of hypertension

HIV PREVENTION WITH PRE-EXPOSURE PROPHYLAXIS: A PRIMER FOR PHARMACISTS. Speaker: Susan MK Lee, PharmD, BCPS, CDE

The Role of Cardiac Rehabilitation in Recovery & Secondary Prevention. Loren M Stabile, MS Cardiac & Pulmonary Rehab Program Manager

Testing the Asymptomatic CAD Patient: When and Why?

Financial Disclosures. Coronary Artery Calcification. Objectives. Coronary Artery Calcium 6/6/2018. Heart Disease Statistics At-a-Glace 2017

HFpEF, Mito or Realidad?

James M. Kirshenbaum, MD, FACC

Tools for Targeting High Risk Patients in Your Practice. Statement of Disclosure

John J.P. Kastelein MD PhD Professor of Medicine Dept. of Vascular Medicine Academic Medial Center / University of Amsterdam

Treatment to reduce cardiovascular risk: multifactorial management

American Osteopathic College of Occupational and Preventive Medicine 2012 Mid-Year Educational Conference St. Petersburg, Florida

The Future of Cardiac Care: Managing Our Patients Together

OBJECTIVES. New Twist To Old Disease: Cardiovascular Update /9/2017. Prevention Pre-operative Coronary Artery Disease

Transcription:

Gregory Roth, MD DISCLOSURE DECLARATION Medication Adherence in Cardiovascular Disease: Drugs Don t Work in Patients Who Don t Take Them FINANCIAL OR OTHER RELATIONSHIP(S) DISCLOSURE: St. Charles Medical Center February 15, 2013 Dr. Roth has indicated that he has not had financial or other relationships with commercial interests, related to this presentation, within the past 12 months. Greg Roth MD MPH Division of Cardiology University of Washington Adherence vs. Compliance The word adherence is preferred by many health care providers, because compliance suggests that the patient is passively following the doctor's orders Osterberg NEJM 2005 Adherence vs. Compliance Drugs don't work in patients who don't take them. C. Everett Koop, M.D. compliance is preferred because it implies a responsibility shared by both patient and physician ACCF/AHA 2011 Expert Consensus Document on Hypertension in the Elderly Why You Should Care Affordable Care Act of 2010 Accountable Care Organizations (ACO) Proposed Measures for ACO Quality Standards LDL cholesterol <100 mg/dl Blood pressure <140/90 mm Hg Goal: Pay to lower BP and LDL, not to see patients Outline Berwick DM; NEJM 2011

Outline Adherence is difficult to measure Direct Methods Direct Observation (Tuberculosis) Measurement of drug in blood Indirect Methods Self-report (interview, questionnaire) Patient diaries Pill counts Electronic medication monitors Prescription fill records Clinical response or physiologic markers Adherence is difficult to measure Direct Methods Direct Observation (Tuberculosis) Measurement of drug in blood Indirect Methods Self-report (interview, questionnaire) Patient diaries Pill counts Electronic medication monitors Prescription fill records Clinical response or physiologic markers Adherence is difficult to measure Direct Methods Direct Observation (Tuberculosis) Measurement of drug in blood Indirect Methods Self-report (interview, questionnaire) Patient diaries Pill counts Electronic medication monitors Prescription fill records Clinical response or physiologic markers Osterberg et al; NEJM 2005 Osterberg et al; NEJM 2005 Does interview style influence detection of nonadherence? 32 patients with hypertension All nonadherent with medications Audio-taped physician visits Physician interview categorized into styles Indirect Simple and Direct Information-intensive Indirect C: The last time I saw you was when we started you on your blood pressure medication. P: Yeah. Uh huh. C: Okay. Have you noticed any changes since you've started taking that medication? P: Well, I go to the bathroom quite often. C: All right. That's a fairly normal effect of the medication. P: (Laughs) Uh huh. C: It's a water pill, a diuretic, and it takes some of the extra fluid out of your body. (Topic shift) Steele DJ et al; J Fam Practice 1990 Steele DJ et al; J Fam Practice 1990

Simple Direct C: (After measuring the patient's blood pressure)... Onetwenty over eighty-eight. That's really good. P: (Laughs) C: You've been taking your medications? P: Oh yes, oh yes. C: Okay. (Topic shift) Steele DJ et al; J Fam Practice 1990 Information-Intensive C: You still taking the Lasix? P: Yup. C: Once in the morning, forty milligrams. And the Inderal? P: Right. C: How much do you take of that? P: Twice a day. Morning and evening (laughs). C: Two tablets? Or is this a forty milligram tablet? P: Right. C: Okay. So it's just one tablet. P: Right. C: Okay. Okay. Good. (Topic shift) Steele DJ et al; J Fam Practice 1990 Does interview style influence detection of nonadherence? Interview Style Indirect Approach N Success Rate Detecting Nonadherence 9 0% Simple Direct 13 62% Informationintensive 10 80% Morisky Compliance Assessment Score Do you ever forget to take your medicine? (1 point) Are you careless at times about taking your medicine? (1 point) When you feel better do you sometimes stop taking your medicine? (1 point) Sometimes if you feel worse when you take the medicine, do you stop taking it? (1 point) Score = less adherent Steele DJ et al; J Fam Practice 1990 Morisky et al; Medical Care 1986 The Morisky Score Correlates with Blood Pressure Control P<0.01 Data for Research Studies Prescription Fill Record Proportion Days Covered Medication Possession Ratio Medication Event Monitoring System (MEMS) Morisky et al; Medical Care 1986 Predicted Adherence (Morisky Score)

Outline Adherence to Statins How long do patients stay on their statins? Statin Adherence Drops Precipitously Over 10 years Number of Monthly Statin Prescriptions Filled in 12 months Retrospective 1990-1999 34,000 Medicaid enrollees starting a statin Retrospective 1996-2004 20,000 Medicare enrollees starting a statin Proportion of Days Covered Benner et al; JAMA 2002 Brookhart et al; Am J Epidemiol 2007 Adherence to Statins Statin Adherence Drops in both Primary and Secondary Prevention Is adherence to statins poor because these people are asymptomatic? Retrospective 1994-1998 140,000 patients in Ontario Adjusted Cox Curve for Adherence with Statins in 3 Cohorts Jackevicius et al; JAMA 2002

Adherence after Acute MI Self-reported Adherence Declines After Acute MI How well do these patients fill prescriptions for all of their cardiac medications? Prospective multicenter 2003-2005 1,500 patients with acute MI All were discharged with ASA, beta blocker, and statin Ho et al; Arch Intern Med 2006 Failure to Fill Clopidogrel and Other Medications is Common after Stent Retrospective How Good Can It Get? Adherence in COURAGE and STICH Frequent nurse visits Free medications Positive reinforcement Medicare Part D 16,000 patients with drug-eluting stent Any prescription fill within 90 days of discharge Roth et al; Circ Cardiovasc Qual Outcomes 2012 Adherence in COURAGE Adherence in COURAGE Randomized controlled trial 2287 individuals with stable CAD Percutaneous coronary intervention and optimal medical therapy vs.optimal medical therapy alone Maron et al; JACC 2010

Adherence in STICH Adherence in STICH Randomized controlled trial 2136 individual with CAD amenable to CABG EF <35% CABG vs. optimal medical therapy Velazquez et al; NEJM 2011 Outline There is hope. Maybe. CAD, Adherence, and Outcomes Discontinuation of Medications after AMI is Associated with Worse Outcome at 1 year Does adherence impact outcomes Log-rank test P<0.001 Ho et al; Arch Intern Med 2006

The Cost of Nonadherence The Healthy Adherer Effect $8,061 Does improved adherence really improve outcomes and save money? $1,375 Roebuck et al; Health Affairs 2011 Nonadherence with Clopidogrel Associated with Death but Not Acute MI CHARM: Healthy Adherers Randomized Trial Retrospective Medicare Part D Adjusted Odds Ratio Death AMI 7500 patients with heart failure class II-IV ARB vs. placebo 16,000 patients with drug-eluting stent No Fill of Clopidogrel in week after discharge 2.5 1.0 Noncompliance with candesartan Compliance with placebo Roth et al; AHA Scientific Sessions 2010 Pfeffer et al; Lancet 2003 Granger et al; Lancet 2005 Adherence to Statins Prevents Trauma? Association Between Adherence to Statin Therapy and Risk of Health-Related Events Outline Dormuth; Circulation 2009

Health Belief Model of Medication Adherence Why is my patient nonadherent? Urquhart in Patient Compliance in Medical Practice and Clinical Trials, Raven Press, 1991 Inui TS; Annals Internal Med 1976 Complex Roots of Medication Nonadherence Depression Predicts Nonadherence with Aspirin after AMI 172 patients with AMI Depression assessed in hospital Given ASA in electronic pill tracker (MEMS) Followed 3 months Ho et al; Circulation 2009 Rieckmann et al; JACC 2006 Higher Dosing Frequency is Associated with Less Adherence Polypharmacy Outpatient pharmacy records 1.8 million people on statins New prescription Osterberg et al; NEJM 2005 Choudhry et al; Arch Intern Med 2011

Polypharmacies Polyproviders Outpatient pharmacy records 1.8 million people on statins New prescription Outpatient pharmacy records 1.8 million people on statins New prescription Choudhry et al; Arch Intern Med 2011 Choudhry et al; Arch Intern Med 2011 Outline A Pharmacist-led Intervention with Blister Packs Medication Adherence During A Trial of Blister Packs vs. Usual Care Lee et al; JAMA 2006 A Physician-led Intervention with Pill Counting Blood Pressure for Physician-led Intervention vs. Control Groups over 60 months 147 physicians randomized Physician pill counting Designated family member supporting adherence Educational handouts 5 years of follow-up Adherence very high: 83-92% Pladevall et al; Circulation 2010 Clinician Strategies That May Improve Adherence Identify Ask about barriers to adherence Adopt a more information-intensive interviewing style Communicate Elicit patient s feelings about ability to adhere Listen to patient and customize to their wishes Dosing Consider more forgiving medications Longer half-lives Depot or extended release medications Transdermal medications Osterberg et al; NEJM 2005

System Strategies That May Improve Adherence Blister packaging Case management Education with behavioral support Reminder calls Pharmacist-led collaboration Interdisciplinary assessment Decision Aids Phone, computer, mail, or video behavioral support or reminders Health coaching Access to online medical records Pharmacist or physician access to adherence data Personalized disease risk communication Shared decision-making tools System Strategies That May Improve Adherence Blister packaging Case management Education with behavioral support Reminder calls Pharmacist-led collaboration Interdisciplinary assessment Decision Aids Phone, computer, mail, or video behavioral support or reminders Health coaching Access to online medical records Pharmacist or physician access to adherence data Personalized disease risk communication Shared decision-making tools Viswanathan et al; Annals of Internal Med 2012 Viswanathan et al; Annals of Internal Med 2012 Limits to Modifying Standard Care Policy or Structural Strategies That May Improve Adherence 174 primary care practices in UK with 2164 patients with LV dysfunction 30 minute pharmacist appointments for medication optimization 3-4 follow-up pharmacist visits New Quality Measures Outpatient Reported to Medicare Pharmacy data prescription measures BP and LDL goal measures Pay for performance Decreasing out-of-pocket costs Novel EHR and mobile technologies Lowrie et al, Eur Heart J, 2012 The End of Cowboy Medicine Outline Recently, you might be interested to know, I met an actual cowboy. He described to me how cowboys do their job today, herding thousands of cattle. They have tightly organized teams, with everyone assigned specific positions and communicating with each other constantly. They have protocols and checklists for bad weather Some interventions may improve adherence. Atul Gawande MD, Harvard Medical School Commencement, 2011

Acknowledgments Thank you. Chris Murray MD, UW Institute for Health Metrics and Evaluation Danny Shen PhD, UW School of Pharmacy Jonathan Skinner PhD, Dartmouth Institute for Health Policy American Heart Association University of Washington Institute for Translational Health Sciences University of Washington Institute for Health Metrics and Evaluation